Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures.

Circulation. Cardiovascular genetics - 1 Oct 2015

Chu Audrey Y, Giulianini Franco, Barratt Bryan J, Ding Bo, Nyberg Fredrik, Mora Samia, Ridker Paul M, Chasman Daniel I

Abstract excerpt

BACKGROUND: Statin therapy influences not only low-density lipoprotein (LDL) cholesterol levels but also LDL-related biomarkers, including non-high-density lipoprotein cholesterol (non-HDL-C), apolipoprotein B, total number of LDL particles, and mean LDL particle size. Recent studies have identified many genetic loci influencing circulating lipid levels and statin-induced LDL cholesterol reduction. However, it is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Markers
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipoproteins, LDL

Share to Polymorphism, Single Nucleotide

Share to Rosuvastatin Calcium

Source

Open in PubMed Open full text

Identifiers

PMID: 26273092
DOI: 10.1161/CIRCGENETICS.114.000962
PMCID: PMC4618030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures.PMID 26273092Read ↗

Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.Semantic proximity Read ↗

Pharmacogenetic determinants of statin-induced reductions in C-reactive protein.Semantic proximity Read ↗

Genome-wide association of lipid-lowering response to statins in combined study populations.Semantic proximity Read ↗

Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterolSemantic proximity Read ↗

Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.Semantic proximity Read ↗

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.Semantic proximity Read ↗

Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.Semantic proximity Read ↗

LDL-cholesterol concentrations: a genome-wide association study.Semantic proximity Read ↗

Pharmacogenomic analysis of low-density lipoprotein receptor 3' untranslated region genetic variants influencing rosuvastatin efficacy in Chinese dyslipidemia patients.Semantic proximity Read ↗

Gene-statin interaction study identifies 9 loci that moderate statin effectiveness in blood lipidsSemantic proximity Read ↗

Sex differences in LDL-C genetic architecture and statin efficacy in All of UsSemantic proximity Read ↗

Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.